カテゴリ： GlobalData, アメリカ, 企業調査

Instrumentation Laboratory Company：企業の製品パイプライン分析2018

◆英語タイトル：Instrumentation Laboratory Company - Product Pipeline Analysis, 2018 Update
◆商品コード：DATA904C0559
◆発行会社（調査会社）：GlobalData
◆発行日：2018年7月
◆ページ数：76
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD1,500 ⇒換算￥222,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD2,250 ⇒換算￥333,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Instrumentation Laboratory Company (IL), a subsidiary of Werfen Life Group, is a medical device company with focus on in vitro diagnostics (IVD) devices. The company develops, manufactures, and distributes IVD instruments, related reagents and controls for hospitals and clinical laboratories. Its major products include critical care systems including whole blood analyzers, CO-Oximeter and whole-blood coagulation system; hemostasis systems including testing systems, reagents, controls and calibrators; and information management systems. IL also offers various quality control products; and services such as advanced automation, quality management, clinical support and product support. The company offers its products to hospitals and independent clinical laboratories the world over. IL is headquartered in Bedford, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Instrumentation Laboratory Company
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Instrumentation Laboratory Company Company Overview 8
Instrumentation Laboratory Company Company Snapshot 8
Instrumentation Laboratory Company Pipeline Products and Ongoing Clinical Trials Overview 8
Instrumentation Laboratory Company – Pipeline Analysis Overview 10
Business Description 10
Instrumentation Laboratory Company – Key Facts 10
Instrumentation Laboratory Company – Major Products and Services 11
Instrumentation Laboratory Company Pipeline Products by Development Stage 13
Instrumentation Laboratory Company Pipeline Products Overview 17
ACL AcuStar – aß2GPI Domain I Assay 17
ACL AcuStar – aß2GPI Domain I Assay Product Overview 17
ACL AcuStar – HIT IgG Test 18
ACL AcuStar – HIT IgG Test Product Overview 18
ACL AcuStar – HIT Total ab Test 19
ACL AcuStar – HIT Total ab Test Product Overview 19
ACL AcuStar – VWF: RCo Assay 20
ACL AcuStar – VWF: RCo Assay Product Overview 20
ACL AcuStar – VWF:Ag Assay 21
ACL AcuStar – VWF:Ag Assay Product Overview 21
ACL TOP 300 CTS System – Apixaban Test 22
ACL TOP 300 CTS System – Apixaban Test Product Overview 22
ACL TOP 300 CTS System – Dabigatran Test 23
ACL TOP 300 CTS System – Dabigatran Test Product Overview 23
ACL TOP 300 CTS system – Global Protein C Pathway Test 24
ACL TOP 300 CTS system – Global Protein C Pathway Test Product Overview 24
ACL TOP 300 CTS System – HIT Assay 25
ACL TOP 300 CTS System – HIT Assay Product Overview 25
ACL TOP 300 CTS System – Rivaroxaban Test 26
ACL TOP 300 CTS System – Rivaroxaban Test Product Overview 26
ACL TOP 300 CTS System – VWF-Ristocetin Cofactor Activity Assay 27
ACL TOP 300 CTS System – VWF-Ristocetin Cofactor Activity Assay Product Overview 27
ACL TOP 350 CTS System – Apixaban Test 28
ACL TOP 350 CTS System – Apixaban Test Product Overview 28
ACL TOP 350 CTS System – Dabigatran Test 29
ACL TOP 350 CTS System – Dabigatran Test Product Overview 29
ACL TOP 350 CTS System – Rivaroxaban Test 30
ACL TOP 350 CTS System – Rivaroxaban Test Product Overview 30
ACL TOP 350 CTS System – VWF Ristocetin Cofactor Activity Assay 31
ACL TOP 350 CTS System – VWF Ristocetin Cofactor Activity Assay Product Overview 31
ACL TOP 500 CTS System – Apixaban Test 32
ACL TOP 500 CTS System – Apixaban Test Product Overview 32
ACL TOP 500 CTS System – Dabigatran Test 33
ACL TOP 500 CTS System – Dabigatran Test Product Overview 33
ACL TOP 500 CTS System – Global Protein C Pathway Test 34
ACL TOP 500 CTS System – Global Protein C Pathway Test Product Overview 34
ACL TOP 500 CTS System – HIT Test 35
ACL TOP 500 CTS System – HIT Test Product Overview 35
ACL TOP 500 CTS System – Rivaroxaban Test 36
ACL TOP 500 CTS System – Rivaroxaban Test Product Overview 36
ACL TOP 500 CTS System – VWF Ristocetin Cofactor Activity Assay 37
ACL TOP 500 CTS System – VWF Ristocetin Cofactor Activity Assay Product Overview 37
ACL TOP 550 CTS System – Apixaban Test 38
ACL TOP 550 CTS System – Apixaban Test Product Overview 38
ACL TOP 550 CTS System – Dabigatran Test 39
ACL TOP 550 CTS System – Dabigatran Test Product Overview 39
ACL TOP 550 CTS System – Rivaroxaban Test 40
ACL TOP 550 CTS System – Rivaroxaban Test Product Overview 40
ACL TOP 550 CTS System – VWF Ristocetin Cofactor Activity Assay 41
ACL TOP 550 CTS System – VWF Ristocetin Cofactor Activity Assay Product Overview 41
ACL TOP 700 – HIT Test 42
ACL TOP 700 – HIT Test Product Overview 42
ACL TOP 700 CTS System – VWF Ristocetin Cofactor Activity Assay 43
ACL TOP 700 CTS System – VWF Ristocetin Cofactor Activity Assay Product Overview 43
ACL TOP 700 System – Apixaban Test 44
ACL TOP 700 System – Apixaban Test Product Overview 44
ACL TOP 700 System – Dabigatran Test 45
ACL TOP 700 System – Dabigatran Test Product Overview 45
ACL TOP 700 System – Global Protein C Pathway Test 46
ACL TOP 700 System – Global Protein C Pathway Test Product Overview 46
ACL TOP 700 System – Rivaroxaban Test 47
ACL TOP 700 System – Rivaroxaban Test Product Overview 47
ACL TOP 750 CTS System – Apixaban Test 48
ACL TOP 750 CTS System – Apixaban Test Product Overview 48
ACL TOP 750 CTS System – Dabigatran Test 49
ACL TOP 750 CTS System – Dabigatran Test Product Overview 49
ACL TOP 750 CTS System – Rivaroxaban Test 50
ACL TOP 750 CTS System – Rivaroxaban Test Product Overview 50
ACL TOP 750 CTS System – VWF Ristocetin Cofactor Activity Assay 51
ACL TOP 750 CTS System – VWF Ristocetin Cofactor Activity Assay Product Overview 51
Dabigatran Direct Thrombin Inhibitor Assay 52
Dabigatran Direct Thrombin Inhibitor Assay Product Overview 52
GEM Premier 4000 Analyzer – BUN 53
GEM Premier 4000 Analyzer – BUN Product Overview 53
GEM Premier 4000 Analyzer – tCO2 Test 54
GEM Premier 4000 Analyzer – tCO2 Test Product Overview 54
HemoSIL ACL AcuStar – VWF:CB Assay 55
HemoSIL ACL AcuStar – VWF:CB Assay Product Overview 55
HemosIL Acustar HIT-Ab (PF4-H) Assay 56
HemosIL Acustar HIT-Ab (PF4-H) Assay Product Overview 56
HemosIL AcuStar Multi-Ab Controls 57
HemosIL AcuStar Multi-Ab Controls Product Overview 57
HemosIL Apixaban Testing Assay 58
HemosIL Apixaban Testing Assay Product Overview 58
HemosIL Dabigatran Calibrators 59
HemosIL Dabigatran Calibrators Product Overview 59
HemosIL Dabigatran Controls 60
HemosIL Dabigatran Controls Product Overview 60
HemosIL Rivaroxaban Calibrators 61
HemosIL Rivaroxaban Calibrators Product Overview 61
POC Enzymatic Creatinine Assay 62
POC Enzymatic Creatinine Assay Product Overview 62
Rivaroxaban Liquid Anti-Xa Assay 63
Rivaroxaban Liquid Anti-Xa Assay Product Overview 63
Instrumentation Laboratory Company – Key Competitors 64
Instrumentation Laboratory Company – Key Employees 65
Instrumentation Laboratory Company – Locations And Subsidiaries 66
Head Office 66
Other Locations & Subsidiaries 66
Recent Developments 67
Instrumentation Laboratory Company, Recent Developments 67
May 07, 2018: Instrumentation Laboratory Worldwide Sales Top $970 M In 2017 67
Oct 16, 2017: Instrumentation Laboratory Receives US FDA Clearance For HemosIL AcuStar HIT-IgG(PF4-H) Assay And Controls 67
Jul 31, 2017: Instrumentation Laboratory Launches GEMweb Plus 500 Custom Connectivity Worldwide 68
Apr 04, 2017: Instrumentation Laboratory Achieves Record Worldwide Sales In 2016 68
Dec 19, 2016: Instrumentation Laboratory Receives US FDA Clearance For New GEM Premier 5000 Critical Care Testing System 69
Oct 11, 2016: Instrumentation Laboratory Launches HemosIL AcuStar VWF:CB Assay In Europe And Other International Markets 70
Sep 26, 2016: Instrumentation Laboratory Launches HemoHub Intelligent Data Manager Worldwide 70
Aug 15, 2016: Instrumentation Laboratory Launches HemosIL ReadiPlasTin Assay Worldwide 71
Aug 15, 2016: Instrumentation Laboratory Launches HemosIL ReadiPlasTin Assay Worldwide 71
Aug 11, 2016: Instrumentation Laboratory Presents New Innovations In Hemostasis At AACC Annual Meeting 71
Appendix 73
Methodology 73
About GlobalData 76
Contact Us 76
Disclaimer 76

List of Tables
Instrumentation Laboratory Company Pipeline Products and Ongoing Clinical Trials Overview 8
Instrumentation Laboratory Company Pipeline Products by Equipment Type 9
Instrumentation Laboratory Company Pipeline Products by Indication 9
Instrumentation Laboratory Company, Key Facts 10
Instrumentation Laboratory Company, Major Products and Services 11
Instrumentation Laboratory Company Number of Pipeline Products by Development Stage 13
Instrumentation Laboratory Company Pipeline Products Summary by Development Stage 14
ACL AcuStar - aß2GPI Domain I Assay - Product Status 17
ACL AcuStar - aß2GPI Domain I Assay - Product Description 17
ACL AcuStar - HIT IgG Test - Product Status 18
ACL AcuStar - HIT IgG Test - Product Description 18
ACL AcuStar - HIT Total ab Test - Product Status 19
ACL AcuStar - HIT Total ab Test - Product Description 19
ACL AcuStar - VWF: RCo Assay - Product Status 20
ACL AcuStar - VWF: RCo Assay - Product Description 20
ACL AcuStar - VWF:Ag Assay - Product Status 21
ACL AcuStar - VWF:Ag Assay - Product Description 21
ACL TOP 300 CTS System - Apixaban Test - Product Status 22
ACL TOP 300 CTS System - Apixaban Test - Product Description 22
ACL TOP 300 CTS System - Dabigatran Test - Product Status 23
ACL TOP 300 CTS System - Dabigatran Test - Product Description 23
ACL TOP 300 CTS system - Global Protein C Pathway Test - Product Status 24
ACL TOP 300 CTS system - Global Protein C Pathway Test - Product Description 24
ACL TOP 300 CTS System - HIT Assay - Product Status 25
ACL TOP 300 CTS System - HIT Assay - Product Description 25
ACL TOP 300 CTS System - Rivaroxaban Test - Product Status 26
ACL TOP 300 CTS System - Rivaroxaban Test - Product Description 26
ACL TOP 300 CTS System - VWF-Ristocetin Cofactor Activity Assay - Product Status 27
ACL TOP 300 CTS System - VWF-Ristocetin Cofactor Activity Assay - Product Description 27
ACL TOP 350 CTS System - Apixaban Test - Product Status 28
ACL TOP 350 CTS System - Apixaban Test - Product Description 28
ACL TOP 350 CTS System - Dabigatran Test - Product Status 29
ACL TOP 350 CTS System - Dabigatran Test - Product Description 29
ACL TOP 350 CTS System - Rivaroxaban Test - Product Status 30
ACL TOP 350 CTS System - Rivaroxaban Test - Product Description 30
ACL TOP 350 CTS System - VWF Ristocetin Cofactor Activity Assay - Product Status 31
ACL TOP 350 CTS System - VWF Ristocetin Cofactor Activity Assay - Product Description 31
ACL TOP 500 CTS System - Apixaban Test - Product Status 32
ACL TOP 500 CTS System - Apixaban Test - Product Description 32
ACL TOP 500 CTS System - Dabigatran Test - Product Status 33
ACL TOP 500 CTS System - Dabigatran Test - Product Description 33
ACL TOP 500 CTS System - Global Protein C Pathway Test - Product Status 34
ACL TOP 500 CTS System - Global Protein C Pathway Test - Product Description 34
ACL TOP 500 CTS System - HIT Test - Product Status 35
ACL TOP 500 CTS System - HIT Test - Product Description 35
ACL TOP 500 CTS System - Rivaroxaban Test - Product Status 36
ACL TOP 500 CTS System - Rivaroxaban Test - Product Description 36
ACL TOP 500 CTS System - VWF Ristocetin Cofactor Activity Assay - Product Status 37
ACL TOP 500 CTS System - VWF Ristocetin Cofactor Activity Assay - Product Description 37
ACL TOP 550 CTS System - Apixaban Test - Product Status 38
ACL TOP 550 CTS System - Apixaban Test - Product Description 38
ACL TOP 550 CTS System - Dabigatran Test - Product Status 39
ACL TOP 550 CTS System - Dabigatran Test - Product Description 39
ACL TOP 550 CTS System - Rivaroxaban Test - Product Status 40
ACL TOP 550 CTS System - Rivaroxaban Test - Product Description 40
ACL TOP 550 CTS System - VWF Ristocetin Cofactor Activity Assay - Product Status 41
ACL TOP 550 CTS System - VWF Ristocetin Cofactor Activity Assay - Product Description 41
ACL TOP 700 - HIT Test - Product Status 42
ACL TOP 700 - HIT Test - Product Description 42
ACL TOP 700 CTS System - VWF Ristocetin Cofactor Activity Assay - Product Status 43
ACL TOP 700 CTS System - VWF Ristocetin Cofactor Activity Assay - Product Description 43
ACL TOP 700 System - Apixaban Test - Product Status 44
ACL TOP 700 System - Apixaban Test - Product Description 44
ACL TOP 700 System - Dabigatran Test - Product Status 45
ACL TOP 700 System - Dabigatran Test - Product Description 45
ACL TOP 700 System - Global Protein C Pathway Test - Product Status 46
ACL TOP 700 System - Global Protein C Pathway Test - Product Description 46
ACL TOP 700 System - Rivaroxaban Test - Product Status 47
ACL TOP 700 System - Rivaroxaban Test - Product Description 47
ACL TOP 750 CTS System - Apixaban Test - Product Status 48
ACL TOP 750 CTS System - Apixaban Test - Product Description 48
ACL TOP 750 CTS System - Dabigatran Test - Product Status 49
ACL TOP 750 CTS System - Dabigatran Test - Product Description 49
ACL TOP 750 CTS System - Rivaroxaban Test - Product Status 50
ACL TOP 750 CTS System - Rivaroxaban Test - Product Description 50
ACL TOP 750 CTS System - VWF Ristocetin Cofactor Activity Assay - Product Status 51
ACL TOP 750 CTS System - VWF Ristocetin Cofactor Activity Assay - Product Description 51
Dabigatran Direct Thrombin Inhibitor Assay - Product Status 52
Dabigatran Direct Thrombin Inhibitor Assay - Product Description 52
GEM Premier 4000 Analyzer - BUN - Product Status 53
GEM Premier 4000 Analyzer - BUN - Product Description 53
GEM Premier 4000 Analyzer - tCO2 Test - Product Status 54
GEM Premier 4000 Analyzer - tCO2 Test - Product Description 54
HemoSIL ACL AcuStar - VWF:CB Assay - Product Status 55
HemoSIL ACL AcuStar - VWF:CB Assay - Product Description 55
HemosIL Acustar HIT-Ab (PF4-H) Assay - Product Status 56
HemosIL Acustar HIT-Ab (PF4-H) Assay - Product Description 56
HemosIL AcuStar Multi-Ab Controls - Product Status 57
HemosIL AcuStar Multi-Ab Controls - Product Description 57
HemosIL Apixaban Testing Assay - Product Status 58
HemosIL Apixaban Testing Assay - Product Description 58
HemosIL Dabigatran Calibrators - Product Status 59
HemosIL Dabigatran Calibrators - Product Description 59
HemosIL Dabigatran Controls - Product Status 60
HemosIL Dabigatran Controls - Product Description 60
HemosIL Rivaroxaban Calibrators - Product Status 61
HemosIL Rivaroxaban Calibrators - Product Description 61
POC Enzymatic Creatinine Assay - Product Status 62
POC Enzymatic Creatinine Assay - Product Description 62
Rivaroxaban Liquid Anti-Xa Assay - Product Status 63
Rivaroxaban Liquid Anti-Xa Assay - Product Description 63
Instrumentation Laboratory Co, Key Employees 65
Instrumentation Laboratory Co, Other Locations 66
Instrumentation Laboratory Co, Subsidiaries 66
Glossary 75

List of Figures
Instrumentation Laboratory Company Pipeline Products by Equipment Type 9
Instrumentation Laboratory Company Pipeline Products by Development Stage 13

★海外企業調査レポート[Instrumentation Laboratory Company：企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Firestone Diamonds Plc：企業の戦略・SWOT・財務分析
    Firestone Diamonds Plc - Strategy, SWOT and Corporate Finance Report Summary Firestone Diamonds Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • PDS Biotechnology Corp-製薬・医療分野：企業M&A・提携分析
    Summary PDS Biotechnology Corp (PDS Biotechnology) is a biopharmaceutical company that develops immunotherapies and vaccines for cancer and infectious disease. The company uses versamune technology, which is immunostimulatory nanoparticle vaccine platform used for the development of cancer immunothe …
  • Morphogenesis Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Morphogenesis Inc (Morphogenesis) is a developer of novel cell and gene therapies to detect, monitor and control cancer. The company manufactures products based on distinct and synergistic technology platforms. It uses technologies such as immunefx cancer immunotherapies, the polymer antibod …
  • Waste Management, Inc. (WM)-エネルギー分野：企業M&A・提携分析
    Summary Waste Management, Inc. (Waste Management) is a provider of comprehensive waste management environmental services. It provides services such as collection, transfer, recycling and resource recovery, and disposal. The company also develops, operates and owns landfill gas-to-energy facilities i …
  • GUD Holdings Limited (GUD)：企業の財務・戦略的SWOT分析
    GUD Holdings Limited (GUD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Hera SpA (HER)：企業の財務・戦略的SWOT分析
    Hera SpA (HER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Jounce Therapeutics Inc (JNCE)：製薬・医療：M&Aディール及び事業提携情報
    Summary Jounce Therapeutics Inc (Jounce) is a clinical stage immunotherapy company that develops therapies that enable the immune system to attack tumors. The company provides JTX-2011, an anti-ICOS monoclonal antibody which stimulates T effector cells to enhance anti-tumor activity; JTX-4014, an an …
  • Main Street America Group Inc：企業の戦略的SWOT分析
    Main Street America Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • M. A. Mortenson Co：戦略・SWOT・企業財務分析
    M. A. Mortenson Co - Strategy, SWOT and Corporate Finance Report Summary M. A. Mortenson Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Aequus Pharmaceuticals Inc (AQS)：企業の財務・戦略的SWOT分析
    Summary Aequus Pharmaceuticals Inc (Aequus Pharmaceuticals) is a drug discovery and development company that develops differentiated drugs. The company’s pipeline products include AQS301, AQS302 and AQS303. Its commercial pipeline comprises ophthalmology products and transplant products. Aequus Phar …
  • Wegmans Food Markets, Inc.：企業の戦略・SWOT・財務分析
    Wegmans Food Markets, Inc. - Strategy, SWOT and Corporate Finance Report Summary Wegmans Food Markets, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Keepmoat Ltd：企業の戦略的SWOT分析
    Keepmoat Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • UCB SA (UCB)：製薬・医療：M&Aディール及び事業提携情報
    Summary UCB SA (UCB) is a biopharmaceutical company that discovers and develops novel medicines and solutions to help treat various diseases. It principally focuses on developing products for the treatment of central nervous system (CNS) and immunology related conditions. The company's key medicines …
  • Marubeni Corporation：企業の戦略・SWOT・財務分析
    Marubeni Corporation - Strategy, SWOT and Corporate Finance Report Summary Marubeni Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Fingrid Oyj：企業の発電所・SWOT分析2018
    Fingrid Oyj - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (execut …
  • Suez Environnement Company：企業の戦略・SWOT・財務情報
    Suez Environnement Company - Strategy, SWOT and Corporate Finance Report Summary Suez Environnement Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Freehold Royalties Ltd (FRU)：企業の財務・戦略的SWOT分析
    Summary Freehold Royalties Ltd (Freehold Royalties), formerly Freehold Royalty Trust is an oil and gas company that offers oil and gas operation and financial performance. Its oil and gas assets generate income from natural gas, crude oil, natural gas liquids and potash deposits. It provides horizon …
  • Manz AG (M5Z)：企業の財務・戦略的SWOT分析
    Manz AG (M5Z) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Auswide Bank Ltd (ABA)：企業の財務・戦略的SWOT分析
    Auswide Bank Ltd (ABA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Husqvarna AB (HUSQ B)：企業の財務・戦略的SWOT分析
    Summary Husqvarna AB (Husqvarna) is an industrial equipment company that produces outdoor power products for forestry, gardening and construction. The company offers wheeled products, electric products, handheld products, watering and hand tools, accessories, and construction products, among others. …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆